or Try an Advanced Search...

    Cancer Vaccine Stocks List

    Symbol Grade Name % Change
    RENB F Renovaro Biosciences Inc. -2.01
    MRNA A Moderna, Inc. -1.78
    INDP F Indaptus Therapeutics, Inc. 0.00
    EVAX D Evaxion Biotech A/S 2.31
    AGEN D Agenus Inc. 7.83
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Agenus Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Vaccine stocks.

    Symbol Grade Name Weight
    GERM C ETFMG Treatments Testing and Advancements ETF 8.45
    BBH C Market Vectors Biotech ETF 5.74
    IDNA C iShares Genomics Immunology and Healthcare ETF 5.14
    GNOM D Global X Genomics & Biotechnology ETF 5.13
    IBBQ C Invesco Nasdaq Biotechnology ETF 4.46
    View all Cancer Vaccine ETFs...
    Compare ETFs
    Compare BBH to IBBQ Compare IDNA to GNOM Compare IDNA to IBBQ

        Cancer Vaccine Stocks Recent News

        Date Stock Title
        May 3 MRNA Moderna First Quarter 2024 Earnings: Beats Expectations
        May 3 MRNA Moderna reports $1.2bn net loss in Q1 2024
        May 3 MRNA Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
        May 2 MRNA Why Moderna Stock Blasted 13% Higher Today
        May 2 MRNA Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
        May 2 MRNA Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
        May 2 MRNA Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
        May 2 MRNA Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
        May 2 MRNA S&P 500, Nasdaq Rise Intraday Amid Moderna Rally as Traders Await Apple Results
        May 2 MRNA Moderna to seek parity for RSV shot as rivals lead in market
        May 2 MRNA Moderna (MRNA) Q1 2024 Earnings Call Transcript
        May 2 MRNA Moderna CEO on the changing COVID market: Pandemic to endemic
        May 2 MRNA Moderna, Inc. (MRNA) Q1 2024 Earnings Call Transcript
        May 2 MRNA Moderna, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 MRNA Moderna Shares Jump After Better-Than-Expected Sales
        May 2 MRNA Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
        May 2 MRNA Moderna Maintains Full-Year Sales Guidance Following First-Quarter Beat
        May 2 MRNA Moderna tops forecasts in Q1 despite COVID-related sales slump
        May 2 MRNA Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline Amid Strategic Shifts
        May 2 MRNA Moderna (MRNA) Reports Q1 Loss, Tops Revenue Estimates
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Agenus Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy
        Cancer Vaccine

        A cancer vaccine is a type of immunotherapy that uses a person’s own immune system to fight cancer. It works by stimulating the body’s natural defenses to recognize and attack cancer cells. Cancer vaccines are designed to target specific types of cancer, such as breast, lung, or prostate cancer. They may also be used to prevent cancer from developing in the first place.

        Browse All Tags